Galectin-7 dysregulates renin-angiotensin-aldosterone and NADPH oxide synthase pathways in preeclampsia
- 1 December 2022
- journal article
- research article
- Published by Elsevier BV in Pregnancy Hypertension
- Vol. 30, 130-136
- https://doi.org/10.1016/j.preghy.2022.09.008
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Pkd1 and Pkd2 Are Required for Normal Placental DevelopmentPLOS ONE, 2010
- The Uterine Placental Bed Renin-Angiotensin System in Normal and Preeclamptic PregnancyEndocrinology, 2009
- High aldosterone-to-renin variants of CYP11B2 and pregnancy outcomeNephrology Dialysis Transplantation, 2009
- Review: Systemic and uteroplacental renin—angiotensin system in normal and pre-eclamptic pregnanciesTherapeutic Advances in Cardiovascular Disease, 2008
- Severe preeclampsia is characterized by increased placental expression of galectin-1The Journal of Maternal-Fetal & Neonatal Medicine, 2008
- Dysregulation of the Circulating and Tissue-Based Renin-Angiotensin System in PreeclampsiaHypertension, 2007
- Sensitizing Effect of Galectin-7 in Urothelial Cancer to Cisplatin through the Accumulation of Intracellular Reactive Oxygen SpeciesCancer Research, 2007
- Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscleAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Evidence for compromised aldosterone synthase enzyme activity in preeclampsiaKidney International, 2004
- AT 1 Receptor Agonistic Antibodies From Preeclamptic Patients Stimulate NADPH OxidaseJournal of the American College of Cardiology, 2003